Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2014
09/09/2014CA2379623C Immunologically significant herpes simplex virus antigens
09/09/2014CA2258721C Chimeric heteromultimer adhesins
09/04/2014WO2014134621A2 Methods and compositions for enhancing an immune response, blocking monocyte migration, amplifying vaccine immunity and inhibiting tumor growth and metastasis
09/04/2014WO2014134547A1 Hiv antigens and antibodies
09/04/2014WO2014134439A1 Immunogenic composition for mers coronavirus infection
09/04/2014WO2014134349A1 Methods of modulating dlk stability
09/04/2014WO2014134311A1 Administration of an anti-gcc antibody-drug conjugate and a dna damaging agent in the treatment of cancer
09/04/2014WO2014134070A1 Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
09/04/2014WO2014133950A1 Particle compositions and methods related thereto
09/04/2014WO2014133728A2 Hhla2 as a novel inhibitor of human immune system and uses thereof
09/04/2014WO2014133316A1 Antibodies against tm4sf5 and anticancer compositions comprising the same
09/04/2014WO2014132210A1 Alpha-synuclein antibodies and uses thereof
09/04/2014WO2014132013A1 Crimean-congo haemorrhagic fever virus antigenic composition
09/04/2014WO2014131844A1 Vaccine against bovine leukemia virus
09/04/2014WO2014131715A1 Anti-mcsp antibodies
09/04/2014WO2014131712A1 Bispecific t cell activating antigen binding molecules
09/04/2014WO2014131711A1 Bispecific t cell activating antigen binding molecules
09/04/2014WO2014108497A3 Vaccine composition comprising e. coli positive for f18 fimbria and/or f4 fimbria
09/04/2014WO2014108484A3 Combination therapy of anti-her3 and anti-her2 antibodies
09/04/2014WO2014107599A3 Compositions and methods for detecting protease activity in biological systems
09/04/2014WO2014074535A9 Flavivirus envelope protein mutations affecting virion disassembly
09/04/2014WO2014016737A9 Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof
09/04/2014WO2013184900A3 Immunogenic compositions and related methods
09/04/2014WO2013123588A9 Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer
09/04/2014WO2013078135A3 Il-1 binding proteins
09/04/2014US20140249467 Cross-protective arenavirus vaccines and their method of use
09/04/2014US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
09/04/2014US20140248609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
09/04/2014US20140248360 Nanoparticle tumour vaccines
09/04/2014US20140248354 Controlled release vaccines and methods for treating brucella diseases and disorders
09/04/2014US20140248337 Liposomal Vaccine Compositions Comprising a Polysaccharide Antigen and a Protein Adjuvant
09/04/2014US20140248320 Adjuvanted influenza b virus vaccines for pediatric priming
09/04/2014US20140248316 Hybrid cells for treating cancer patients
09/04/2014US20140248315 Methods and compositions for enhancing an immune response, blocking monocyte migration, amplifying vaccine immunity and inhibiting tumor growth and metastasis
09/04/2014US20140248313 Combination adjuvant formulation
09/04/2014US20140248312 Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
09/04/2014US20140248310 Cationic metal oxides for use as vaccine adjuvants
09/04/2014US20140248309 Dna promoters and anthrax vaccines
09/04/2014US20140248308 Affenadenovirus (gorilla) or adenoviral vectors and methods of use
09/04/2014US20140248307 Affenadenovirus (gorilla) or adenoviral vectors and methods of use
09/04/2014US20140248304 Non-hemolytic llo fusion proteins and methods of utilizing same
09/04/2014US20140248296 Sustained drug delivery system
09/04/2014US20140248292 Compositions and methods for treating cancer
09/04/2014US20140248291 Modulation of Cellular Migration
09/04/2014US20140248289 Methods and Compositions for the Treatment of Respiratory Conditions Via NKG2D Inhibition
09/04/2014US20140248286 Anti-hemagglutinin antibodies and methods of use
09/04/2014US20140248282 Novel anti-ddr1 antibody having anti-tumor activity
09/04/2014US20140248280 Anti-erbb3 antibodies in combination with paclitaxel for treatment of gynecological cancers
09/04/2014US20140248277 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/04/2014US20140248276 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/04/2014US20140248275 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/04/2014US20140248274 Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
09/04/2014US20140248273 Vaccine based on staphylococcal superantigen-like 3 protein (ssl3)
09/04/2014US20140248267 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same
09/04/2014US20140248264 Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
09/04/2014US20140248262 Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor
09/04/2014US20140248260 Use of toll-like receptor agonist for treating cancer
09/04/2014DE10297513C5 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes
09/03/2014EP2772269A2 IL-17 binding proteins
09/03/2014EP2772268A1 Cancer stem cell-specific molecule
09/03/2014EP2772267A2 Immunogenic compositions and methods
09/03/2014EP2772266A1 Equine Rhinitis vaccine
09/03/2014EP2772265A2 Recombinant HCMV and RHCMV vectors and uses thereof
09/03/2014EP2772260A2 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
09/03/2014EP2772251A1 Protamine/RNA nanoparticles for immunostimulation
09/03/2014EP2771694A2 Monoclonal antibodies and methods of use
09/03/2014EP2771690A1 Use of mycobacterium avium paratuberculosis peptides to diagnose type 1 diabetes
09/03/2014EP2771688A1 Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
09/03/2014EP2771469A1 Plastid-expressed mycobacterium tuberculosis vaccine antigens esat-6 and mtb72f fused to cholera toxin b subunit
09/03/2014EP2771453A1 Diatom-based vaccines
09/03/2014EP2771366A1 Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes
09/03/2014EP2771363A1 Cd44 monoclonal antibody for the treatment of b-cell chronic lymphocytic leukemia and other hematological malignancies
09/03/2014EP2771361A1 Bispecific immunobinders directed against tnf and il-17
09/03/2014EP2771360A1 Immunobinders directed against sclerostin
09/03/2014EP2771355A1 A MODIFIED EFFECTOR CELL (OR CHIMERIC RECEPTOR) FOR TREATING DISIALOGANGLIOSIDE Gp2-EXPRESSING NEOPLASIA
09/03/2014EP2771352A1 Vaccine
09/03/2014EP2771033A1 Protein formulations containing amino acids
09/03/2014EP2771031A1 Humanized antibodies that recognize alpha-synuclein
09/03/2014EP2771030A1 Compositions and methods for treatment of proteinopathies
09/03/2014EP2771029A1 Antibody formulations and methods
09/03/2014EP2771017A1 A method of treating mucus hypersecretion
09/02/2014USRE45105 Method of treating cancer by co-administration of anticancer agents
09/02/2014US8822664 Antibodies
09/02/2014US8822653 Plasma kallikrein binding proteins
09/02/2014US8822652 Monoclonal antibodies that bind B7H6 and uses thereof
09/02/2014US8822649 Anti-CLTA4, anti-GLUT2 protein for the treatment of type 1 diabetes
09/02/2014US8822645 Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
09/02/2014US8822644 Method of treating cancer comprising a VEGF-B antagonist
09/02/2014US8822427 Methods and compositions to protect aquatic invertebrates from disease
09/02/2014US8822423 Affinity peptides toward infliximab
09/02/2014US8822418 Treatment of muscular dystrophies and related disorders
09/02/2014US8822405 Uses of mammalian cytokines and agonists; related reagents
09/02/2014US8822223 Mature dendritic cell compositions and methods for culturing same
09/02/2014US8822192 Human rotavirus vaccine strains and diagnostics
09/02/2014US8822182 Chimeric antigen-specific T cell-activating polypeptides
09/02/2014US8822169 HMG1 antibody for treating inflammatory conditions
09/02/2014US8821943 Methods and compositions for targeted delivery of therapeutic agents
09/02/2014US8821897 Viral adjuvants
09/02/2014US8821896 Purified Plasmodium and vaccine composition
09/02/2014US8821895 Streptococcus pyogenes antigens and corresponding DNA fragments
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 1823